查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球基于细胞的检测市场——行业规模、份额、趋势、机会、预测、按产品/服务、按应用、按最终用户、按地区、竞争对手分析 (2018-2028)
市场调查报告书
商品编码
1244144

全球基于细胞的检测市场——行业规模、份额、趋势、机会、预测、按产品/服务、按应用、按最终用户、按地区、竞争对手分析 (2018-2028)

Cell Based Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Products & Services, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 112 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

在预测期内，基于细胞的检测的全球市场预计将出现令人瞩目的增长。

人们对治疗慢性病的新药的需求不断增长。 在各种疾病爆发中使用治疗药物和增加研究活动是推动全球细胞检测市场增长的两个关键因素。 政府在医疗保健领域的支出不断增加以及对药物毒性筛查的需求不断增长，预计将推动世界不同地区的市场增长。 此外，对罕见疾病有效治疗的需求不断增长，预计将进一步推动对基于细胞的检测的需求，加速市场增长到 2028 年。 此外，人们越来越意识到使用新疗法的好处以及对降低全球药物发现相关成本的需求不断增长，预计将在预测期内进一步支持基于细胞的检测市场。 例如，2021 年 11 月，Menarini Silicon Biosystems 推出了 CELLSEARCH，这是一种实验室开发的测试，可帮助使用血液样本对多发性骨髓瘤细胞进行计数。

对基于细胞的检测不断增长的需求推动了市场增长

在预测期内，对药物开发鑑定和优化程序的需求不断增长是推动市场发展的主要因素。 越来越多的製药和生物技术公司采用该技术也是推动该市场增长的关键因素。 此外，猪流感和 COVID-19 等疾病爆发的风险增加，以及研究活动比例的增加，预计也将推动多年来的市场增长。 从2020年9月28日至2021年5月22日，美国实验室检测的818,939份呼吸道标本中有1,675份（0.2%）在美国检测出流感病毒呈阳性。 低劳动力和原材料成本以及越来越多的提供药物发现服务的 CRO 公司预计将在预测期内产生有利可图的增长。 药物发现项目的兴起和越来越多地采用战略方法，例如与多家公司合作开发新药，将进一步推动未来的市场增长。

药物发现活动的增加推动了市场增长

关节炎、糖尿病、癫痫、癌症和心血管疾病等与生活方式相关的疾病日益流行，这将推动基于细胞的检测市场的增长。 政府机构正在投资研发部门，用于诊断癌症、糖尿病和自身免疫性疾病等慢性病的新药开发，预计在预测期内将产生有利可图的增长。 多年来，全球对治疗流行性疾病的新药需求不断增长，推动了市场的增长。 例如，2021 年 5 月，美国 FDA 授予 T-Detect COVID-19 常规 T 细胞检测紧急使用授权 (EUA)。 同样，在预测期内，越来越多的治疗药物发现调查和市场参与者对 FDA 批准的竞争日益激烈，预计将产生有利的增长。

市场细分

近期发展

  • 例如，2022 年 9 月，弗劳恩霍夫研究所的研究人员开发了 Proxidrugs，它利用基于细胞的废物处理系统，作为传染病、癌症和阿尔茨海默病的潜在治疗选择。。
  • 例如，2021 年 11 月，Menarini Silicon Biosystems 推出了 CELLSEARCH，这是一种实验室开发的测试，可帮助使用血液样本对多发性骨髓瘤细胞进行计数。
  • 例如，2022 年 8 月，LifeNet Health LifeSciences 宣布将推出一项新的基于细胞的检测服务，以支持药物发现开发。

报告范围

本报告将全球基于细胞的检测市场分为以下几类，以及下面详述的行业趋势：

基于细胞的检测市场，按产品/服务分类：

  • 试剂
  • 检测试剂盒
  • 微孔板
  • 探针和标籤
  • 细胞系
  • 其他

基于细胞的检测市场，按应用分类：

  • 用于临床研究
  • 药物发现和药物开发
  • 其他

最终用户基于细胞的检测市场：

  • 生物技术公司、製药公司
  • 学术和研究机构等
  • 委託研究机构

按地区划分的细胞检测市场：

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿联酋

竞争格局

公司概况：对全球细胞检测市场主要参与者的深入分析。

可自定义：

根据市场数据，TechSci Research 根据公司的具体需求提供定制服务。 该报告可以定制为：

公司信息

  • 对其他市场参与者（最多 5 家公司）进行深入分析和概况分析。

内容

第 1 章概述

  • 市场定义
  • 市场范围
    • 目标市场
    • 研究目标年份
    • 主要市场细分

第二章研究方法论

  • 调查目的
  • 基线调查方法
  • 主要行业合作伙伴
  • 主要协会和次要信息
  • 调查方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章执行摘要

  • 市场概览
  • 主要市场细分概述
  • 主要市场参与者概览
  • 主要地区/国家概览
  • 市场驱动因素、挑战和趋势概述

第 4 章 VOC（客户之声）

第5章临床试验分析

  • 正在进行的临床试验
  • 已完成临床试验
  • 中止的临床试验
  • 管道细分（按开发阶段）
  • 管道细分（按状态
  • 管道细分（按研究类型）
  • 按地区划分的渠道细分
  • 临床试验热图

第 6 章基于细胞的检测的全球市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品/服务（试剂、检测试剂盒、微孔板、探针/标籤、细胞係等）
    • 按应用（临床研究、药物开发、其他）
    • 最终用户（生物技术/製药公司、学术/研究机构、合同研究机构）
    • 按地区
    • 按公司分类（2022 年）
  • 市场地图
    • 按产品/服务
    • 通过申请
    • 最终用户
    • 按地区

第 7 章北美基于细胞的分析市场前景

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品/服务
    • 通过申请
    • 最终用户
    • 按国家
  • 北美：国家/地区分析
    • 美国
    • 加拿大
    • 墨西哥

第 8 章欧洲基于细胞的检测市场前景

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品/服务
    • 通过申请
    • 最终用户
    • 按国家
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 9 章亚太地区基于细胞的检测市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品/服务
    • 通过申请
    • 最终用户
    • 按国家
  • 亚太地区：国家/地区分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第 10 章南美洲基于细胞的检测市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品/服务
    • 通过申请
    • 最终用户
    • 按国家
  • 南美洲：：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 11 章中东和非洲基于细胞的检测市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品/服务
    • 通过申请
    • 最终用户
    • 按国家
  • MEA：国家分析
    • 南非基于细胞的检测
    • 沙特阿拉伯基于细胞的检测
    • 阿联酋基于细胞的分析

第 12 章市场动态

  • 司机
  • 做

第13章市场趋势与发展

  • 近期趋势
  • 併购
  • 产品发布

第14章竞争格局

  • 业务概览
  • 提供的产品
  • 最新趋势
  • 财务信息（公开数据）
  • 管理团队
  • SWOT 分析
    • Corning, Inc.
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Lonza Group AG
    • Promega Corporation
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Charles River Laboratories International, Inc.
    • Menarini Silicon Biosystems, Inc.

第15章 战略建议

简介目录
Product Code: 14420

The Global Cell-Based Assays Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing demand for novel drugs for treating chronic diseases. The use of therapeutic drugs during various disease outbreaks, along with the growing number of research activities are two significant factors responsible for the growth of global cell-based assay market. Rising government expenditure in the healthcare sector and the rising need for toxicity screening in drugs are expected to drive market growth across different parts of the globe. Additionally, the growing demand for efficient treatment for rare diseases is further expected to increase the demand for cell-based assays, thereby fuelling market growth through 2028. Besides, growing awareness of the advantages of using new treatments along with the increasing demand to reduce the costs associated with drug discovery across the globe, are further expected to support the cell-based assays market during the forecast period. For instance, in November 2021, Menarini Silicon Biosystems, launched its CELLSEARCH, a laboratory-developed test to aid the enumeration of multiple myeloma cells using a blood sample.

Growing Demand for Cell-Based Assays Will Propel the Market Growth

Increasing demand for identification and optimization procedures for drug development is a major factor that will boost market growth during the forecast period. Growing adoption by pharmaceutical and biotechnology firms is another important factor driving the growth of this market. Furthermore, the increasing risk of disease outbreaks like swine flu, and COVID-19 and the growing rate of research activities are also expected to fuel the market growth over the years. From September 28, 2020-May 22, 2021, in the United States, 1,675 (0.2%) of 818,939 respiratory specimens tested by U.S. clinical laboratories were positive for the influenza virus. The low labor and raw material costs along with more and more CRO companies providing drug discovery services are expected to create lucrative growth during the forecast period. Increasing growth in drug discovery projects and rising adoption of strategic approaches, like collaboration with different companies for developing new drugs, will further propel the growth of the market over the years.

Increasing Number of Drug Discovery Activities Will Fuel the Market Growth

The increasing prevalence of lifestyle disorders like arthritis, diabetes, epilepsy, cancer, cardiovascular diseases, etc., will enhance the growth of the cell-based assay market. Government organizations are investing in the research and development sector for developing new drugs for the diagnosis of chronic diseases such as cancer, diabetes, and autoimmune disorders, which is expected to create lucrative growth during the forecast period. The rising demand for novel drugs across the world for the treatment of pandemic diseases is propelling the growth of the market over the years. For instance, in May 2021, U.S. FDA granted Emergency Use Authorization (EUA) for the T-Detect COVID-19 routine T-cell test. Similarly, the rising number of research for therapeutic drug discovery and growing competition for FDA approvals among the market players is expected to create lucrative growth during the forecast period.

Market Segmentation

The global cell-based assay market can be segmented by products and services, application, end users, and region. Based on products and services, the market can be segmented into Reagents, Assay Kits, Microplates, Probes & Labels, Cell Lines, and Others. Based on application, the market can be segmented into Clinical Research, Drug Discovery & Development, and Others. Based on the end user, the market can be differentiated into Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, and Contract Research Organizations. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global cell-based assays market on account of the growing demand for the identification and optimization of the novel drug in the country.

Market PlayersCorning, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Lonza Group AG, Promega Corporation, F. Hoffmann-La Roche AG, Merck KGaA, Charles River Laboratories International, Inc., Menarini Silicon Biosystems, Inc. are some of the leading players operating in the Global Cell-Based Assays Market.

Recent Development

  • For instance, in September 2022, researchers at the Fraunhofer Institute developed Proxidrugs to utilize a cells-based waste disposal system as a potential therapeutic option for infections, cancer, and Alzheimer's disease.
  • For instance, in November 2021, Menarini Silicon Biosystems, launched its CELLSEARCH, a laboratory-developed test to aid the enumeration of multiple myeloma cells using a blood sample.
  • For instance, in August 2022, LifeNet Health LifeSciences announced the launch of its new cell-based assay services to aid in drug discovery and development.

Report Scope:

In this report, Global Cell-Based Assays Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell-Based Assays Market, By Products & Services:

  • Reagents
  • Assay Kits
  • Microplates
  • Probes & Labels
  • Cell Lines
  • Others

Cell-Based Assays Market, By Application:

  • Clinical Research
  • Drug Discovery & Development
  • Others

Cell-Based Assays Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutions
  • Contract Research Organizations

Cell-Based Assays Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Cell-Based Assays Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Type
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Cell Based Assays Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Products & Services (Reagents, Assay Kits, Microplates, Probes & Labels, Cell Lines, Others)
    • 6.2.2. By Application (Clinical Research, Drug Discovery & Development, Others)
    • 6.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Contract Research Organizations)
    • 6.2.4. By Region
    • 6.2.5. By Company (2022)
  • 6.3. Market Map
    • 6.3.1. By Products & Services
    • 6.3.2. By Application
    • 6.3.3. By End User
    • 6.3.4. By Region

7. North America Cell Based Assays Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Products & Services
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Cell Based Assays Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Products & Services
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Canada Cell Based Assays Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Products & Services
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Mexico Cell Based Assays Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Products & Services
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User

8. Europe Cell Based Assays Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Products & Services
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Cell Based Assays Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Products & Services
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Cell Based Assays Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Products & Services
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Cell Based Assays Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Products & Services
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Cell Based Assays Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Products & Services
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Cell Based Assays Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Products & Services
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Asia-Pacific Cell Based Assays Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Products & Services
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Cell Based Assays Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Products & Services
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. India Cell Based Assays Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Products & Services
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Japan Cell Based Assays Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Products & Services
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User
    • 9.3.4. South Korea Cell Based Assays Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Products & Services
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia Cell Based Assays Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Products & Services
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By End User

10. South America Cell Based Assays Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Products & Services
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cell Based Assays Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Products & Services
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Cell Based Assays Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Products & Services
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Cell Based Assays Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Products & Services
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Middle East and Africa Cell Based Assays Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Products & Services
    • 11.2.2. By Application
    • 11.2.3. By End User
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Cell Based Assays Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Products & Services
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Cell Based Assays Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Products & Services
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Cell Based Assays Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Products & Services
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Financials (As Reported)
  • 14.5. Key Personnel
  • 14.6. SWOT Analysis
    • 14.6.1. Corning, Inc.
    • 14.6.2. Bio-Rad Laboratories, Inc.
    • 14.6.3. Thermo Fisher Scientific Inc.
    • 14.6.4. Danaher Corporation
    • 14.6.5. Lonza Group AG
    • 14.6.6. Promega Corporation
    • 14.6.7. F. Hoffmann-La Roche AG
    • 14.6.8. Merck KGaA
    • 14.6.9. Charles River Laboratories International, Inc.
    • 14.6.10. Menarini Silicon Biosystems, Inc.

15. Strategic Recommendations